IL-1R 与 NFKBIZ 通路介导间变性大细胞淋巴瘤的免疫调节反应及免疫治疗疗效 The IL-1R and NFKBIZ pathway mediates immunoregulatory responses and immunotherapy efficacy in anaplastic large cell lymphoma. PubMed 2025/11/12 发表LeukemiaQ1 · IF 8.8(JCR 2025) 靶点:CD30技术:CAR-NK技术:NK 细胞技术:基因编辑淋巴瘤白血病